跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Cetirizine Hydrochloride/Pseudoephedrine Hydrochloride
首页
药物
Cetirizine Hydrochloride/Pseudoephedrine Hydrochloride
Cetirizine Hydrochloride/Pseudoephedrine Hydrochloride
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。
Oral particle including pseudoephedrine hydrochloride and cetirizine dihydrochloride
US 2009169633 A1
申请人: LIAO TA-PING
优先权: 2007
US
2 件公开
Preparation containing Cetirizine Hydrochloride and hydrochloric pseudoephedrine and its prepn. method
CN 1498617 A
申请人: XINYI PHARMACEUTICAL FACTORY
优先权: 2002
CN
Oral microparticles containing pseudoephedrine hydrochloride and cetirizine hydrochloride
CN 101357130 B
申请人: EVEREST PHARMACEUTICAL IND CO LTD
优先权: 2007
CN
Cetirizine and pseudoephedrine sustained-release capsule and preparation method thereof
CN 101474166 B
申请人: QINGDAO HUANGHAI PHARMACEUTICAL CO LTD
优先权: 2009
CN
Preparation for treating allergic rhinitis and preparation method thereof
CN 102302497 A
申请人: TIANSHENG PHARMACEUTICAL GROUP CO LTD
优先权: 2011
CN
Cetirizine hydrochloride pseudo ephedrine sustained-release pellet and preparation method thereof
CN 104490880 A
申请人: HARBIN SHENGJI PHARMACEUTICAL CO LTD
优先权: 2014
CN
Cetirizine pseudoephedrine sustained-release capsule and preparation method thereof
CN 110974807 A
申请人: BAI XIPING
优先权: 2019
CN
EXTENDED RELEASE COMPOSITIONS OF PSEUDOEPHEDRINE OR ITS PHARMACEUTICALLY ACCEPTABLE SALT THEREOF
US 2023248667 A1
申请人: AUROBINDO PHARMA LTD
优先权: 2022
US
药物
反馈
